Abstract
The paper by Zahid Rasul Niazi, Naqab Khan, Samiullah Khan, Mehboob Alam, Mohammad Amjad Kamal entitled “Potential Application of Venom Proteins in Designing of Medicines for Treating Human Neurodegenerative Disorders” is being retracted from the Protein & Peptide Letters, Volume 25, Issue 7, due to the use of Figure from an earlier publication without permission or attribution. In addition, some text was copied and used in the paper without quotation marks or proper citation.
Protein & Peptide Letters
Title:Retraction Notice: Potential Application of Venom Proteins in Designing of Medicines for Treating Human Neurodegenerative Disorders
Volume: 25 Issue: 7
Author(s): Zahid Rasul Niazi, Naqab Khan, Samiullah Khan, Mehboob Alam and Mohammad Amjad Kamal*
Affiliation:
- Novel Global Community Educational Foundation, Sydney,Australia
Abstract: The paper by Zahid Rasul Niazi, Naqab Khan, Samiullah Khan, Mehboob Alam, Mohammad Amjad Kamal entitled “Potential Application of Venom Proteins in Designing of Medicines for Treating Human Neurodegenerative Disorders” is being retracted from the Protein & Peptide Letters, Volume 25, Issue 7, due to the use of Figure from an earlier publication without permission or attribution. In addition, some text was copied and used in the paper without quotation marks or proper citation.
Export Options
About this article
Cite this article as:
Niazi Rasul Zahid , Khan Naqab , Khan Samiullah , Alam Mehboob and Kamal Amjad Mohammad *, Retraction Notice: Potential Application of Venom Proteins in Designing of Medicines for Treating Human Neurodegenerative Disorders, Protein & Peptide Letters 2018; 25 (7) . https://dx.doi.org/10.2174/0929866525666180614120407
DOI https://dx.doi.org/10.2174/0929866525666180614120407 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial [Hot Topic: Drugs and Pregnancy (Guest Editor: Zaneta Kimber-Trojnar)]
Current Pharmaceutical Biotechnology In Search of Novel and Therapeutically Significant Melatoninergic Ligands
Recent Patents on CNS Drug Discovery (Discontinued) Semicarbazone Analogs as Anticonvulsant Agents: A Review
Central Nervous System Agents in Medicinal Chemistry Role of Sirtuins and Calorie Restriction in Neuroprotection: Implications in Alzheimers and Parkinsons Diseases
Current Pharmaceutical Design Automated Electrophysiology in Drug Discovery
Current Pharmaceutical Design Concurrent Estimation of Gabapentin and Nortriptyline Hydrochloride in their Combined Dosage Form Using OPA-β-Mercaptoethanol Derivatization by Spectrophotometric and Spectrofluorimetric Methods
Current Pharmaceutical Analysis Review of the Phytochemistry and Biological Activity of Cissus incisa Leaves
Current Topics in Medicinal Chemistry Antidepressants and Neuroinflammation: Can Antidepressants Calm Glial Rage Down?
Mini-Reviews in Medicinal Chemistry Antiepileptic Drugs in Clinical Development: Differentiate or Die?
Current Pharmaceutical Design Pharmacological Benefits of Active Components of Natural Products Against Traumatic Brain Injury - A Review
Current Pharmacogenomics and Personalized Medicine Upregulated Long Non-coding RNA ALMS1-IT1 Promotes Neuroinflammation by Activating NF-κB Signaling in Ischemic Cerebral Injury
Current Pharmaceutical Design Clinical Evidence of Herb-Drug Interactions: A Systematic Review by the Natural Standard Research Collaboration
Current Drug Metabolism Neutralization of Interleukin-1β Reduces Vasospasm and Alters Cerebral Blood Vessel Density Following Experimental Subarachnoid Hemorrhage in Rats
Current Neurovascular Research Novel Kynurenic Acid Analogues in the Treatment of Migraine and Neurodegenerative Disorders: Preclinical Studies and Pharmaceutical Design
Current Pharmaceutical Design Old Strategies and New Perspectives in Modulating the Endocannabinoid System
Current Bioactive Compounds Prediction of Disease-Related Genes Based on Hybrid Features
Current Proteomics The Clinics and Etiology of Preeclampsia
Current Women`s Health Reviews Possible Role of NUCB2/nesfatin-1 in Adipogenesis
Current Pharmaceutical Design Recent Progress in Transition-Metal-Catalyzed C-N Cross-Couplings: Emerging Approaches Towards Sustainability
Current Organic Synthesis Pharmacological Tools to Activate Microglia and their Possible use to Study Neural Network Patho-physiology
Current Neuropharmacology